Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-10-14 14:18Core Viewpoint - The stock of Steady Medical (300888) has shown a slight increase, with significant net inflows from institutional investors, indicating positive market sentiment towards the company [1][4]. Financial Performance - As of the latest report, Steady Medical's total revenue for the first half of 2025 reached 5.296 billion yuan, a year-on-year increase of 31.31% [3] - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year, while the net profit excluding non-recurring items was 461 million yuan, reflecting a 40.9% increase [3] - The company's second-quarter performance showed a revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% [3] Market Position - Steady Medical's total market capitalization is 22.554 billion yuan, ranking 4th in the beauty and personal care industry [3] - The company has a net asset value of 12.276 billion yuan, leading the industry [3] - The price-to-earnings ratio (P/E) stands at 22.92, which is lower than the industry average of 30.51, indicating a potentially undervalued stock [3] Investment Sentiment - In the past 90 days, 19 institutions have rated the stock, with 16 buy ratings and 3 hold ratings, suggesting strong institutional confidence [4] - The average target price set by institutions for the stock is 55.11 yuan, indicating potential upside from the current price [4] Capital Flow - On October 14, 2025, the stock experienced a net inflow of 14.4665 million yuan from institutional investors, accounting for 7.86% of the total trading volume [1][2] - Retail investors showed a net outflow of 16.0052 million yuan, representing 8.69% of the total trading volume, indicating a divergence in sentiment between institutional and retail investors [1][2]